BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 8644308)

  • 1. Report of the Third Banff Conference on Allograft Pathology (July 20-24, 1995) on classification and lesion scoring in renal allograft pathology.
    Solez K; Benediktsson H; Cavallo T; Croker B; Demetris AJ; Drachenberg C; Emancipator S; Furness PN; Gaber LW; Gibson IW; Gough J; Gupta R; Halloran P; Häyry P; Kashgarian M; Marcussen N; Massy ZA; Mihatsch MJ; Morozumi K; Noronha I; Olsen S; Papadimitriou J; Paul LC; Picken M; Racusen LC; Ramos EL; Randhawa P; Rayner DC; Rush D; Sanfilippo F; Taskinen E; Trpkov K; Truong L; Yamaguchi Y; Yilmaz S
    Transplant Proc; 1996 Feb; 28(1):441-4. PubMed ID: 8644308
    [No Abstract]   [Full Text] [Related]  

  • 2. The Banff classification of renal allograft pathology: where do we go from here?
    Racusen L; Rayner D; Trpkov K; Olsen S; Solez K
    Transplant Proc; 1996 Feb; 28(1):486-8. PubMed ID: 8644322
    [No Abstract]   [Full Text] [Related]  

  • 3. Electron-microscopic peritubular capillary lesion is a specific and useful diagnostic indicator for chronic rejection of renal allografts showing less specific morphologic lesions in the cyclosporine era.
    Morozumi K; Oikawa T; Fukuda M; Sugito K; Takeuchi O; Usami T; Fujinami T; Yokoyama I; Takagi H; Takeda A; Koyama K; Yoshida A; Haba T; Tominaga Y; Uchida K
    Transplant Proc; 1997; 29(1-2):89-92. PubMed ID: 9123167
    [No Abstract]   [Full Text] [Related]  

  • 4. Improvement of lesion quantitation for the Banff schema for renal allograft rejection.
    Racusen LC
    Transplant Proc; 1996 Feb; 28(1):489-90. PubMed ID: 8644323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Banff schema four years later.
    Solez K; Racusen L; Rayner D; Olsen S; Halloran P
    Transplant Proc; 1996 Feb; 28(1):450-2. PubMed ID: 8644311
    [No Abstract]   [Full Text] [Related]  

  • 6. The Banff classification of renal allograft pathology: where do we go from here?
    Racusen LC; Rayner DC; Trpkov K; Olsen S; Solez K
    Transplant Proc; 1995 Oct; 27(5):2561-3. PubMed ID: 7482825
    [No Abstract]   [Full Text] [Related]  

  • 7. Protocol core biopsy as intermediate efficacy end-point in chronic kidney allograft rejection.
    Yilmaz S; Taskinen E; Häyry P; Isoniemi H
    Transplant Proc; 1996 Feb; 28(1):491-3. PubMed ID: 8644324
    [No Abstract]   [Full Text] [Related]  

  • 8. An evaluation of the Banff classification of early renal allograft biopsies and correlation with outcome.
    Bates WD; Davies DR; Welsh K; Gray DW; Fuggle SV; Morris PJ
    Nephrol Dial Transplant; 1999 Oct; 14(10):2364-9. PubMed ID: 10528659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. International standardization of criteria for histologic diagnosis of chronic rejection in renal allografts.
    Solez K
    Clin Transplant; 1994 Jun; 8(3 Pt 2):345-50. PubMed ID: 8061379
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Follow-up of patients with borderline changes in renal allograft biopsies: clinical outcome and evaluation of other histological features in addition to tubulitis.
    Papadimitriou J; Drachenberg C; Anderson L; Bartlett S; Johnson L; Klassen D; Hoehn-Saric E; Weir M; Schweitzer E
    Transplant Proc; 1996 Feb; 28(1):517-8. PubMed ID: 8644334
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical validity of Banff grading of chronic rejection in renal transplantation.
    Oh CK; Jeong HJ; Kim YS; Kim MS; Choi KH; Lee HY; Han DS; Park K
    Transplant Proc; 1996 Jun; 28(3):1441-2. PubMed ID: 8658731
    [No Abstract]   [Full Text] [Related]  

  • 12. Pathology of the renal allograft rejection.
    Olsen S
    Monogr Pathol; 1979; 20():327-55. PubMed ID: 388207
    [No Abstract]   [Full Text] [Related]  

  • 13. Morphological criteria of chronic rejection: differential diagnosis, including cyclosporine nephropathy.
    Mihatsch MJ; Ryffel B; Gudat F
    Transplant Proc; 1993 Apr; 25(2):2031-7. PubMed ID: 8470264
    [No Abstract]   [Full Text] [Related]  

  • 14. The Banff 97 working classification of renal allograft pathology.
    Racusen LC; Solez K; Colvin RB; Bonsib SM; Castro MC; Cavallo T; Croker BP; Demetris AJ; Drachenberg CB; Fogo AB; Furness P; Gaber LW; Gibson IW; Glotz D; Goldberg JC; Grande J; Halloran PF; Hansen HE; Hartley B; Hayry PJ; Hill CM; Hoffman EO; Hunsicker LG; Lindblad AS; Yamaguchi Y
    Kidney Int; 1999 Feb; 55(2):713-23. PubMed ID: 9987096
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pathology of renal allograft].
    Morozumi K; Kodera K; Takeda A
    Rinsho Byori; 1991 Jul; Suppl 90():82-101. PubMed ID: 1920858
    [No Abstract]   [Full Text] [Related]  

  • 16. [Current topics of the rejection pathology in human renal allografts].
    Morozumi K; Fukuda M; Takeda A
    Hinyokika Kiyo; 1998 May; 44(5):353-7. PubMed ID: 9656109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical markers of renal tubular injury and cyclosporin nephrotoxicity in kidney allograft biopsies.
    García Del Moral R; Navarro N; Montes A; Aguilar D; Aneiros J
    Nephron; 1992; 62(1):121-2. PubMed ID: 1436283
    [No Abstract]   [Full Text] [Related]  

  • 18. Chronic cyclosporine nephropathy in renal transplantation.
    Bennett WM; DeMattos A; Meyer MM; Andoh T; Barry JM
    Transplant Proc; 1996 Aug; 28(4):2100-3. PubMed ID: 8769166
    [No Abstract]   [Full Text] [Related]  

  • 19. Immunohistochemical characterization of glomerular and tubulointerstitial infiltrates in renal transplant patients with chronic allograft dysfunction.
    Divella C; Rossini M; Loverre A; Schena A; Maiorano A; Gesualdo V; Zaza G; Grandaliano G; Schena FP
    Nephrol Dial Transplant; 2010 Dec; 25(12):4071-7. PubMed ID: 20595199
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proteinuria after renal allograft: assessment based on severity and causes.
    Jeong HJ; Kim YS; Oh CK; Park K; Choi IJ
    Transplant Proc; 1994 Aug; 26(4):2132-3. PubMed ID: 8066695
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.